Pulmonary vein isolation as the fifth column of heart failure therapy: a case report.

Viktoria Santner, Martin Manninger, Anna-Sophie Eberl, Laura Stix, Daniel Scherr

Abstract readCase Reports

In one paragraph

Article in European heart journal. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Viktoria SantnerDivision of Cardiology, University Heart Center and Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, Graz 8036, Austria.

Martin ManningerDivision of Cardiology, University Heart Center and Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, Graz 8036, Austria.ORCID https://orcid.org/0000-0002-0545-4373

Anna-Sophie EberlDivision of Cardiology, University Heart Center and Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, Graz 8036, Austria.ORCID https://orcid.org/0000-0002-1991-9899

Laura StixDivision of Cardiology, University Heart Center and Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, Graz 8036, Austria.

Daniel ScherrDivision of Cardiology, University Heart Center and Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, Graz 8036, Austria.ORCID https://orcid.org/0000-0001-5868-5493

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Heart failure (HF) and atrial fibrillation often coexist and exacerbate each other, creating a therapeutic challenge when both are present. This case presents a patient with suspected tachycardia-induced cardiomyopathy (TIC) progressing to cardiogenic shock, managed with guideline-directed medical therapy (GDMT) for HF and pulmonary vein isolation (PVI) as an additional therapeutic pillar. Case summary: We report the case of a 57-year-old male with Conclusion: Treatment of HF with GDMT should be performed simultaneously and harmonized with rhythm and rate control. This case highlights the role of early rhythm control and the potential of left ventricular ejection fraction improvement after PVI in patients with TIC.

Indexed as

Cardiogenic shockCase reportCatheter ablationHeart failurePulmonary vein isolationTachycardia-induced cardiomyopathy

Identifiers

PMID41368045

DOI10.1093/ehjcr/ytaf560

PMCPMC12684712

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.